Commercial Wegovy pill launches in UK as first daily oral GLP1 for weight management PharmaTimesOption offers oncedaily semaglutide tablets for adults living with obesityMetabolic & GLP-1Read full story pharminent July 6, 2026 (Last updated: July 8, 2026) PharmaTimes Option offers oncedaily semaglutide tablets for adults living with obesity Metabolic & GLP-1 Read full story Post navigation Previous: UK, pharma industry pilot rapid access routes for medicinesNext: Roche looks to Astex in $515m breast cancer deal Related Stories Commercial Lilly’s $23B Q2 soars over expectations but Foundayo lags Novo’s rival oral GLP-1 pharminent August 5, 2026 Commercial Leqembi sales grow again after subcutaneous approvals pharminent July 29, 2026 Commercial Tryngolza charts blockbuster course after FDA’s hypertriglyceridemia approval pharminent June 26, 2026
